DelSiTech has at its disposal a world-class organization that has taken succesfully pharmaceutical and biomaterial products to the market before.
Lasse Leino, PhD, Chief Executive Officer
Dr. Leino is the company’s President and Chief Executive Officer and has more than 18 years life science business experience. He is the founder and former President and CEO of BioCis Pharma Ltd as well as the first CEO and COO of Laurantis Pharma Ltd. Previously, Dr. Leino has worked in various R&D management positions in Orion Pharma, BioTie Therapies Ltd, and AstraZeneca in Lund, Sweden. Dr. Leino holds a PhD in biochemistry and has a position as Adjunct Professor in immunology at the University of Turku, Finland.
Cora Griffin, PhD, Business Development Director
Dr. Cora Griffin is Director, Head of Business Development of DelSiTech. She joined the company in 2014. Dr. Griffin is a business development and licensing professional with more than 10 years experience in pharma and biotech industry. Previously, she worked at Q Chip Ltd, a polymer-based drug delivery company and Arrow Therapeutics, an antiviral drug development company owned by AstraZeneca. Dr. Griffin holds a PhD in virology.
Mika Jokinen, DSc, Research Director
Dr. Jokinen is a co-founder of DelSiTech and Research Director of in the company since 2006. In addition, he is a Principal Lecturer in chemical and biochemical engineering at the Turku University of Applied Sciences. He has almost 20 years R&D experience in silica-based biomaterials. Dr. Jokinen holds a Doctor of Science in Technology and has a position as Adjunct Professor in Medical Biomaterials at Åbo Akademi University, Turku, Finland.
Eeva Kari, MD, Medical Director
Dr. Kari serves as Medical Director in DelSiTech. She has more than 15 years experience in clinical development and medical consulting in pharma and biotech industry. Previously, she worked as Medical Director in Laurantis Pharma. Dr. Kari is specialist in pulmonary diseases.